Forges Partnership with Veritas Genetics to Accelerate Creation of Trusted Marketplace for Genomic Data as a Foundation for Data-Driven Medicine SAN FRANCISCO & BOSTON–Nebula Genomics announced today that it has raised $4.3M million in seed financing with participation from 10 leading venture capital firms. The funds will support the company’s mission to usher in the […]
(ANN ARBOR, Mich. ) Swift Biosciences today announced early access availability of its Swift Amplicon HS Panels, a new, high-sensitivity targeted amplicon library preparation kit for next-generation sequencing (NGS) of liquid biopsy samples, including cell-free DNA (cfDNA). This addition to Swift’s targeted NGS portfolio facilitates the detection and validation of mutations occurring at 0.25-3.0% frequency among […]
Cambridge, United Kingdom – Congenica, the global provider of clinical genomics interpretation software, today announced the appointment of Mrs Wendy Britten as its new Chief Financial Officer (CFO), effective 1st September, 2018. Mrs Britten will have overall control and responsibility for all financial aspects of the business and will play a key role in business development […]
BC Platforms, a world leader in genomic data management and analytics, today announces that it has partnered with Proteus Genomics, a clinical reference lab specializing in pharmacogenomics, to streamline genomic and healthcare data integration. This new approach will optimize Proteus Genomics’ handling of genomic data, taking one step further towards the implementation of precision medicine. […]
Furthers 10x Leadership across Genomics Applications; Brings Inventors of ATAC-seq Technology to 10x PLEASANTON, CA.—10x Genomics, a leader in the genomics field, today announced its first acquisition with Epinomics, a pioneer in the growing epigenetics space. The acquisition will give 10x Genomics ATAC-seq technology and fundamental IP to accelerate discoveries and further research in epigenomics, […]
AUCKLAND, NZ. Biomatters today announces that Geneious, its world-leading desktop suite of molecular biology and sequence analysis tools, will be renamed to Geneious Prime later this year. Geneious began as a way to reduce time spent on managing and analyzing biological data and is now widely used in biotechnology and academic research. Over half a […]
Co-development and implementation of a new CRISPR-based screening technology platform to address critical gaps in target ID and validation Single cell RNAseq-linked pooled CRISPR screening offers unparalleled depth of screening data and biological insight New platform will further enhance Horizon’s CRISPR screening capabilities Cambridge, UK: Horizon Discovery Group plc (LSE: HZD) (“Horizon”, “the Company”, or […]
On August 24, 2018, the 6th meeting of the China-Thailand Joint Commission on trade investment, and economic cooperation took place in Bangkok, Thailand. During the conference, BGI’s cooperation with the Chulabhorn Royal Academy and Eastern Economic Corridor (EEC) office of Thailand was officially announced. Dr. Somkid Jatusripitak, Deputy Prime Minister of Thailand; Dr. Uttama Savanayana, […]
Enabling Growing Genomic Applications in Chinese Clinical Market SAN DIEGO–Illumina, Inc. (NASDAQ:ILMN) today announced that its MiSeq™Dx Sequencing Systemreceived the approval certificate from the China National Drug Administration (CNDA). This is Illumina’s first CNDA-cleared, next-generation sequencing (NGS) system in China. In accordance with the clearance, Illumina can now market and sell the MiSeqDx Sequencing System to hospitals […]
PORTLAND, OR – August 22, 2018 – MolecularMD today announces it has validated Thermo Fisher Scientific’s Oncomine™ Tumor Mutation Load Assay for clinical research trials to aid immunotherapy drug development programs for the pharmaceutical industry. The latest approach in the evolving field of immuno-oncology, tumor mutation burden (TMB) analysis is rapidly becoming an independent predictor […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
